RIGL
Price
$18.66
Change
+$0.22 (+1.19%)
Updated
Dec 18, 10:54 AM (EDT)
WVE
Price
$14.24
Change
-$0.21 (-1.45%)
Updated
Dec 18, 11:15 AM (EDT)
71 days until earnings call
Ad is loading...

RIGL vs WVE

Header iconRIGL vs WVE Comparison
Open Charts RIGL vs WVEBanner chart's image
Rigel Pharmaceuticals
Price$18.66
Change+$0.22 (+1.19%)
Volume$150
CapitalizationN/A
Wave Life Sciences
Price$14.24
Change-$0.21 (-1.45%)
Volume$5.86K
CapitalizationN/A
RIGL vs WVE Comparison Chart
Loading...
RIGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WVE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RIGL vs. WVE commentary
Dec 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RIGL is a Hold and WVE is a Hold.

COMPARISON
Comparison
Dec 18, 2024
Stock price -- (RIGL: $18.45 vs. WVE: $14.45)
Brand notoriety: RIGL and WVE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RIGL: 62% vs. WVE: 90%
Market capitalization -- RIGL: $325M vs. WVE: $2.2B
RIGL [@Biotechnology] is valued at $325M. WVE’s [@Biotechnology] market capitalization is $2.2B. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RIGL’s FA Score shows that 0 FA rating(s) are green whileWVE’s FA Score has 0 green FA rating(s).

  • RIGL’s FA Score: 0 green, 5 red.
  • WVE’s FA Score: 0 green, 5 red.
According to our system of comparison, both RIGL and WVE are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RIGL’s TA Score shows that 4 TA indicator(s) are bullish while WVE’s TA Score has 6 bullish TA indicator(s).

  • RIGL’s TA Score: 4 bullish, 4 bearish.
  • WVE’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, WVE is a better buy in the short-term than RIGL.

Price Growth

RIGL (@Biotechnology) experienced а -10.26% price change this week, while WVE (@Biotechnology) price change was -3.44% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.65%. For the same industry, the average monthly price growth was +1.44%, and the average quarterly price growth was +4.25%.

Reported Earning Dates

RIGL is expected to report earnings on Aug 06, 2024.

WVE is expected to report earnings on Feb 27, 2025.

Industries' Descriptions

@Biotechnology (-3.65% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
WVE($2.2B) has a higher market cap than RIGL($325M). WVE YTD gains are higher at: 186.139 vs. RIGL (27.241). RIGL has higher annual earnings (EBITDA): 13.7M vs. WVE (-143.36M). WVE has more cash in the bank: 311M vs. RIGL (61.1M). WVE has less debt than RIGL: WVE (27.2M) vs RIGL (60.2M). RIGL has higher revenues than WVE: RIGL (157M) vs WVE (53.6M).
RIGLWVERIGL / WVE
Capitalization325M2.2B15%
EBITDA13.7M-143.36M-10%
Gain YTD27.241186.13915%
P/E Ratio68.33N/A-
Revenue157M53.6M293%
Total Cash61.1M311M20%
Total Debt60.2M27.2M221%
FUNDAMENTALS RATINGS
RIGL vs WVE: Fundamental Ratings
RIGL
WVE
OUTLOOK RATING
1..100
5575
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
75
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10099
PRICE GROWTH RATING
1..100
3935
P/E GROWTH RATING
1..100
90100
SEASONALITY SCORE
1..100
33n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

WVE's Valuation (75) in the Biotechnology industry is in the same range as RIGL (88). This means that WVE’s stock grew similarly to RIGL’s over the last 12 months.

WVE's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as RIGL (100). This means that WVE’s stock grew similarly to RIGL’s over the last 12 months.

WVE's SMR Rating (99) in the Biotechnology industry is in the same range as RIGL (100). This means that WVE’s stock grew similarly to RIGL’s over the last 12 months.

WVE's Price Growth Rating (35) in the Biotechnology industry is in the same range as RIGL (39). This means that WVE’s stock grew similarly to RIGL’s over the last 12 months.

RIGL's P/E Growth Rating (90) in the Biotechnology industry is in the same range as WVE (100). This means that RIGL’s stock grew similarly to WVE’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RIGLWVE
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 6 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 22 days ago
82%
Bullish Trend 2 days ago
79%
Declines
ODDS (%)
Bearish Trend 6 days ago
86%
Bearish Trend 6 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
86%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
86%
View a ticker or compare two or three
Ad is loading...
RIGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WVE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GGIPX20.78N/A
N/A
Goldman Sachs GQG Ptnrs Intl Opps P
BGEFX14.09-0.02
-0.15%
Baillie Gifford International Growth 4
GLDCX19.38-0.11
-0.56%
Gabelli Gold C
RYZCX28.60-0.22
-0.76%
Rydex Precious Metals C
LMASX36.40-0.44
-1.19%
ClearBridge Small Cap C

RIGL and

Correlation & Price change

A.I.dvisor indicates that over the last year, RIGL has been loosely correlated with RCUS. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if RIGL jumps, then RCUS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RIGL
1D Price
Change %
RIGL100%
-3.61%
RCUS - RIGL
38%
Loosely correlated
-2.60%
NTLA - RIGL
37%
Loosely correlated
-1.87%
AGIO - RIGL
37%
Loosely correlated
-1.71%
WVE - RIGL
36%
Loosely correlated
+7.43%
ALT - RIGL
35%
Loosely correlated
-6.67%
More

WVE and

Correlation & Price change

A.I.dvisor indicates that over the last year, WVE has been loosely correlated with PRQR. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if WVE jumps, then PRQR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WVE
1D Price
Change %
WVE100%
+7.43%
PRQR - WVE
47%
Loosely correlated
+19.03%
KRRO - WVE
40%
Loosely correlated
+3.32%
ATNF - WVE
39%
Loosely correlated
N/A
RIGL - WVE
35%
Loosely correlated
-3.61%
ABOS - WVE
35%
Loosely correlated
-0.51%
More